US 7943772
Crystalline forms of an 8-azabicyclo(3.2.1)octane compound
granted A61KA61K31/46A61K31/485
Quick answer
US patent 7943772 (Crystalline forms of an 8-azabicyclo(3.2.1)octane compound) held by Theravance, Inc. expires Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue May 17 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/46, A61K31/485, A61K45/06, A61P